carisoprodol has been researched along with Pregnancy in 7 studies
Carisoprodol: A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)
carisoprodol : A carbamate ester that is the mono-N-isopropyl derivative of meprobamate (which is a significant metabolite). Carisoprodol interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alteration in pain perception. It is used as a muscle relaxant in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm.
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 28-year-old woman with severe back muscle spasm took carisoprodol 2800 mg/day before and throughout an uncomplicated pregnancy and while exclusively breast-feeding her infant during the first month after birth." | 7.74 | High-dose carisoprodol during pregnancy and lactation. ( Ambrose, PJ; Briggs, GG; Nageotte, MP; Padilla, G, 2008) |
| "A 28-year-old woman with severe back muscle spasm took carisoprodol 2800 mg/day before and throughout an uncomplicated pregnancy and while exclusively breast-feeding her infant during the first month after birth." | 3.74 | High-dose carisoprodol during pregnancy and lactation. ( Ambrose, PJ; Briggs, GG; Nageotte, MP; Padilla, G, 2008) |
| "Carisoprodol is a relaxant muscular-skeleton associated with sore muscles and appropriate studies have not been performed on carisoprodol effects on fetuses and mothers." | 1.62 | Toxicity of Somadril Compound on Fetal Ileum Tissues of Albino Rats. ( Ahmed Abd Rabou, M; Alhumaidi Alotaibi, M, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed Abd Rabou, M | 1 |
| Alhumaidi Alotaibi, M | 1 |
| Blicharski, T | 1 |
| Burdan, F | 1 |
| Małkiewicz, J | 1 |
| Piechota, G | 1 |
| Briggs, GG | 1 |
| Ambrose, PJ | 1 |
| Nageotte, MP | 1 |
| Padilla, G | 1 |
| Chan, PC | 1 |
| van der Kleijn, E | 1 |
7 other studies available for carisoprodol and Pregnancy
| Article | Year |
|---|---|
Toxicity of Somadril Compound on Fetal Ileum Tissues of Albino Rats.
Topics: Animals; Carisoprodol; Female; Fetus; Gestational Age; Ileum; Muscle Relaxants, Central; Pregnancy; | 2021 |
Blockade of reticular formation activity, due to carisoprodol maternal administration, and its effects on rat skeleton development.
Topics: Abnormalities, Drug-Induced; Animals; Bone and Bones; Bone Diseases, Developmental; Carisoprodol; Fe | 2002 |
High-dose carisoprodol during pregnancy and lactation.
Topics: Adult; Back Pain; Biological Transport; Breast Feeding; Carisoprodol; Female; Humans; Infant, Newbor | 2008 |
Treatment of muscle cramp.
Topics: Calcium; Carisoprodol; Female; Humans; Muscle Cramp; Pregnancy | 1982 |
Reproductive toxicology. Carisoprodol.
Topics: Animals; Birth Weight; Body Weight; Carisoprodol; Dose-Response Relationship, Drug; Drinking; Eating | 1997 |
NTP toxicity studies of carisoprodol (CAS No. 78-44-4) administered by Gavage to F344/N rats and B6C3F1 mice.
Topics: Animals; Carcinogens; Carisoprodol; Chemistry, Pharmaceutical; Corn Oil; Dosage Forms; Excipients; F | 2000 |
Kinetics of distribution and metabolism of ataractics of the meprobamate-group in mice.
Topics: Adipose Tissue; Animals; Autoradiography; Brain Chemistry; Carbamates; Carisoprodol; Central Nervous | 1969 |